Biolife Solutions (BLFS) Gross Margin (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Gross Margin data on file, last reported at 63.62% in Q1 2026.

• On a quarterly basis, Gross Margin fell 349.0% year-over-year to 63.62% in Q1 2026; TTM through Mar 2026 was 58.62%, a 333.0% increase from a year earlier, with the FY2025 full-year figure at 64.56%, down 255.0% from the prior year.
• Gross Margin for Q1 2026 stood at 63.62%, up from 66.44% in the prior quarter.
• Over the last five years, Gross Margin for BLFS reached as high as 207.86% in Q4 2023 and fell as low as 66.44% in Q4 2025.
• Historically, Gross Margin has averaged 79.54% across 5 years, with a median of 94.71% in 2022.
• Across the five-year window, Gross Margin surged 11865 bps in 2023 and slumped 25208 bps in 2024, its largest moves.
• Year by year, Gross Margin stood at 89.21% in 2022, then soared by 133 bps to 207.86% in 2023, then sank by 121 bps to 44.22% in 2024, then slumped by 50 bps to 66.44% in 2025, then jumped by 196 bps to 63.62% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 63.62% in Q1 2026, 66.44% in Q4 2025, and 99.98% in Q3 2025.